Literature DB >> 23954948

Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Shengli Song, Miaomiao Han, Han Zhang, Yuanxia Wang, Hong Jiang.   

Abstract

HLA-A*02 is the most prevalent and polymorphic major histocompatibility complex (MHC) allele family in humans. Functional differences have been revealed among subtypes, demanding further subtyping of HLA-A*02 in basic and clinical settings. However, the fast growing polymorphisms render traditional primer- or probe-based typing methods impractical and result in increasing ambiguities in direct sequence-based typing. In this study, we combined group-specific amplification and mono-allelic sequencing to design and validate a simple scheme for the complete screening and accurate subtyping of all 540 reported HLA-A*02 alleles. This scheme could be performed in routine labs to facilitate studies with an interest in HLA-A*02.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954948      PMCID: PMC4002391          DOI: 10.1038/cmi.2013.33

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  24 in total

1.  Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.

Authors:  T Sudo; N Kamikawaji; A Kimura; Y Date; C J Savoie; H Nakashima; E Furuichi; S Kuhara; T Sasazuki
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

2.  A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles.

Authors:  P Krausa; M J Browning
Journal:  Tissue Antigens       Date:  1996-03

3.  A PCR-SSP method to specifically select HLA-A*0201 individuals for immunotherapeutic studies.

Authors:  S A Gatz; H Pohla; D J Schendel
Journal:  Tissue Antigens       Date:  2000-06

4.  Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations.

Authors:  P Krausa; M Brywka; D Savage; K M Hui; M Bunce; J L Ngai; D L Teo; Y W Ong; D Barouch; C E Allsop
Journal:  Tissue Antigens       Date:  1995-04

5.  Rapid characterization of HLA class I alleles by gene mapping using ARMS PCR.

Authors:  P Krausa; D Barouch; J G Bodmer; M J Browning
Journal:  Eur J Immunogenet       Date:  1995-06

6.  A novel subtype of A2 (A*0217) isolated from the South American Indian B-cell line AMALA.

Authors:  A Selvakumar; C B Granja; M Salazar; S M Alosco; E J Yunis; B Dupont
Journal:  Tissue Antigens       Date:  1995-05

7.  Characterization of a novel HLA-A2 variant, A*0214, by ARMS-PCR and DNA sequencing.

Authors:  P Krausa; D Barouch; J G Bodmer; A V Hill; C Mason; A J McMichael; M J Browning
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.

Authors:  M J Browning; J A Madrigal; P Krausa; H Kowalski; C E Allsopp; A M Little; S Turner; E J Adams; K L Arnett; W F Bodmer
Journal:  Tissue Antigens       Date:  1995-03

9.  Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles.

Authors:  N Cereb; P Maye; S Lee; Y Kong; S Y Yang
Journal:  Tissue Antigens       Date:  1995-01

10.  HLA-A2 subtypes are functionally distinct in peptide binding and presentation.

Authors:  D Barouch; T Friede; S Stevanović; L Tussey; K Smith; S Rowland-Jones; V Braud; A McMichael; H G Rammensee
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  6 in total

1.  Simplification of complex DNA profiles using front end cell separation and probabilistic modeling.

Authors:  Nancy A Stokes; Cristina E Stanciu; Emily R Brocato; Christopher J Ehrhardt; Susan A Greenspoon
Journal:  Forensic Sci Int Genet       Date:  2018-07-17       Impact factor: 4.882

Review 2.  Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.

Authors:  Joseph G Skeate; Andrew W Woodham; Mark H Einstein; Diane M Da Silva; W Martin Kast
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

Review 3.  T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.

Authors:  Apostolia-Maria Tsimberidou; Karlyle Van Morris; Henry Hiep Vo; Stephen Eck; Yu-Feng Lin; Jorge Mauricio Rivas; Borje S Andersson
Journal:  J Hematol Oncol       Date:  2021-06-30       Impact factor: 17.388

Review 4.  Strategies for Manipulating T Cells in Cancer Immunotherapy.

Authors:  Hyang-Mi Lee
Journal:  Biomol Ther (Seoul)       Date:  2022-03-10       Impact factor: 4.231

5.  Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma.

Authors:  Tan-Huy Chu; Manh-Cuong Vo; Thangaraj Jaya Lakshmi; Seo-Yeon Ahn; Mihee Kim; Ga-Young Song; Deok-Hwan Yang; Jae-Sook Ahn; Hyeoung-Joon Kim; Sung-Hoon Jung; Je-Jung Lee
Journal:  Transl Oncol       Date:  2022-04-09       Impact factor: 4.243

6.  An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.

Authors:  Tamara Verkerk; Sofie J I Koomen; Kyra J Fuchs; Marieke Griffioen; Robbert M Spaapen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-08       Impact factor: 12.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.